AVMET-TNG 500

Description

AVMET-TNG 500 is a dual-action medication specifically designed for the treatment of type 2 diabetes mellitus, particularly in adults who need additional glycemic control beyond monotherapy. The medication combines two pharmacologically active ingredients: Teneligliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin Hydrochloride, a well-established biguanide antidiabetic agent.

Teneligliptin works by inhibiting the DPP-4 enzyme, which results in prolonged incretin hormone activity. These hormones, GLP-1 and GIP, increase insulin release and decrease glucagon secretion in a glucose-dependent manner. This helps to modulate blood sugar AVMET-TNG 500 is a dual-action medication specifically designed for the treatment of type 2 diabetes mellitus, particularly in adults who need additional glycemic control beyond monotherapy. The medication combines two pharmacologically active ingredients: Teneligliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin Hydrochloride, a well-established biguanide antidiabetic agent.

Teneligliptin works by inhibiting the DPP-4 enzyme, which results in prolonged incretin hormone activity. These hormones, GLP-1 and GIP, increase insulin release and decrease glucagon secretion in a glucose-dependent manner. This helps to modulate blood sugar levels, particularly after meals, without significantly increasing the risk of hypoglycemia.asing the risk of hypoglycemia.